Diagnostic options · UAE

Genetics tests in Dubai & UAE

Compare available Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

2,789

Listed price range

-1.00–50,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetics test prices

Showing 2566–2580 of 2,789 matching tests.

Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-3907 TMLHE Gene Sequencing for X-Linked Autism Susceptibility Type 6 (NGS) Test This diagnostic test evaluates the TMLHE gene for pathogenic variants associated with X-linked autism susceptibility type 6.	Peripheral Whole Blood (EDTA) or Saliva Sample	14–21 Working Days (3–4 Weeks)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TMLHE gene"] Parameters [] Preparation ["Genetic counseling session required", "No fasting or medication changes needed unless advised by physician"] Indications ["Suspected X-linked autism susceptibility", "Family planning", "Genetic risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 51995-8 ICD-10: Z15.89 Clinical summary This diagnostic test evaluates the TMLHE gene for pathogenic variants associated with X-linked autism susceptibility type 6.
TEST-4303 TMPO Gene Dilated Cardiomyopathy Type 1T (Genetic Test) This genetic test identifies pathogenic mutations in the TMPO gene associated with familial dilated cardiomyopathy type 1T.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic mutations in the TMPO gene"] Parameters [] Preparation ["No fasting or special preparation needed", "Mandatory genetic counseling session beforehand"] Indications ["Symptomatic patients suspected of dilated cardiomyopathy type 1T", "Individuals with a significant family history of dilated cardiomyopathy", "Screening of at-risk relatives"] Measurement technique Confirm with laboratory Codes LOINC: 82186-6 ICD-10: I42.0 Clinical summary This genetic test identifies pathogenic mutations in the TMPO gene associated with familial dilated cardiomyopathy type 1T.
TEST-5648 TMPRSS3 Gene Deafness, Autosomal Recessive Type 8/10 Genetic Test This test evaluates the TMPRSS3 gene for mutations associated with autosomal recessive nonsyndromic hearing loss types DFNB8 and DFNB10.	Peripheral whole blood (3-5 mL in EDTA tube)	3–4 Weeks (express available on request)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["TMPRSS3 gene sequence", "Pathogenic variants in TMPRSS3"] Parameters [] Preparation [] Indications ["Diagnosis of autosomal recessive nonsyndromic hearing loss (DFNB8/DFNB10)", "Genetic counseling for families with hereditary deafness", "Carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: H90.3 Clinical summary This test evaluates the TMPRSS3 gene for mutations associated with autosomal recessive nonsyndromic hearing loss types DFNB8 and DFNB10.
TEST-4686 TNFRSF11A Gene Sequencing for Autosomal Recessive Osteopetrosis Type 7 (NGS) Test This test evaluates the TNFRSF11A gene for mutations associated with autosomal recessive osteopetrosis type 7.	Whole blood (EDTA) or FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["TNFRSF11A gene sequence", "Single-nucleotide variants", "Small insertions and deletions", "Copy-number variants"] Parameters [] Preparation [] Indications ["Clinical suspicion of osteopetrosis type 7", "Family history of osteopetrosis", "Genetic counselling for at-risk relatives", "Reproductive planning"] Measurement technique Confirm with laboratory Codes LOINC: 81322-7 ICD-10: Q78.2 Clinical summary This test evaluates the TNFRSF11A gene for mutations associated with autosomal recessive osteopetrosis type 7.
TEST-4687 TNFRSF11A Gene: Familial Expansile Osteolysis Test This test identifies mutations in the TNFRSF11A gene associated with familial expansile osteolysis.	Whole Blood (Peripheral)	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["TNFRSF11A gene mutations", "Single-nucleotide variants", "Small insertions/deletions"] Parameters [] Preparation [] Indications ["Suspected familial expansile osteolysis (FEO)", "Associated bone disorders", "Overlapping dermatologic and immunologic symptoms", "Family screening for at-risk relatives"] Measurement technique Confirm with laboratory Codes LOINC: 78337-6 ICD-10: M89.58, Q78.8, Z15.89 Clinical summary This test identifies mutations in the TNFRSF11A gene associated with familial expansile osteolysis.
TEST-4653 TNFRSF11B Gene (Paget Disease, Juvenile) Genetic Test This test evaluates the TNFRSF11B gene for mutations associated with juvenile Paget disease (hereditary hyperphosphatasia).	Peripheral whole blood, FTA card blood spot	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Full coding sequence of the TNFRSF11B gene", "Single nucleotide variants (SNVs)", "Insertions/Deletions (Indels)"] Parameters [] Preparation ["No specific fasting required", "No medication adjustments needed unless advised by physician"] Indications ["Suspected juvenile Paget disease based on clinical presentation", "Family history of juvenile Paget disease", "Need for definitive molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: M88.89 Clinical summary This test evaluates the TNFRSF11B gene for mutations associated with juvenile Paget disease (hereditary hyperphosphatasia).
TEST-4937 TNFRSF13C Gene Common Variable Immunodeficiency Type 4 (CVID4) Genetic Test This genetic test identifies pathogenic variants in the TNFRSF13C gene associated with Common Variable Immunodeficiency type 4 (CVID4).	Whole blood (EDTA tube), extracted DNA, or dried blood spot (FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TNFRSF13C gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of recent blood transfusions or transplants"] Indications ["Suspected Common Variable Immunodeficiency type 4 (CVID4)", "Diagnosis of primary immunodeficiency"] Measurement technique Confirm with laboratory Codes LOINC: 91856-9 ICD-10: D83.9 Clinical summary This genetic test identifies pathogenic variants in the TNFRSF13C gene associated with Common Variable Immunodeficiency type 4 (CVID4).
TEST-5954 TNFRSF1A Gene Periodic Fever (TRAPS) Genetic Test This genetic test identifies pathogenic variants in the TNFRSF1A gene, which are the cause of Tumor Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS).	Peripheral Whole Blood (EDTA tube)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TNFRSF1A gene", "Copy Number Variations (CNV) in the TNFRSF1A gene"] Parameters [] Preparation [] Indications ["Clinical suspicion of TRAPS based on symptoms and family history", "Guiding therapy with IL-1 inhibitors", "Screening at-risk family members"] Measurement technique Confirm with laboratory Codes LOINC: 83504-5 ICD-10: M04.1 Clinical summary This genetic test identifies pathogenic variants in the TNFRSF1A gene, which are the cause of Tumor Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS).
TEST-4289 TNNC1 Gene Cardiomyopathy Dilated Type 1Z Genetic Test This test evaluates the TNNC1 gene for pathogenic variants associated with dilated cardiomyopathy type 1Z.	Peripheral whole blood, extracted DNA, or dried blood spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TNNC1 gene", "Copy Number Variations (CNV) in the TNNC1 gene"] Parameters [] Preparation ["No specific fasting required.", "Inform phlebotomist of any medications."] Indications ["Diagnosis of dilated cardiomyopathy type 1Z", "Family screening for TNNC1-related cardiomyopathy", "Risk stratification for sudden cardiac death"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: I42.0 Clinical summary This test evaluates the TNNC1 gene for pathogenic variants associated with dilated cardiomyopathy type 1Z.
TEST-5412 TNNI2 Gene Arthrogryposis, Distal, Type 2B Genetic Test This genetic test identifies pathogenic variants in the TNNI2 gene associated with Distal Arthrogryposis Type 2B.	Whole blood (EDTA), extracted DNA, or buccal swab	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TNNI2 gene", "Coding region and splice sites of TNNI2"] Parameters [] Preparation [] Indications ["Clinical suspicion of Distal Arthrogryposis Type 2B", "Family planning", "Genetic counseling"] Measurement technique Confirm with laboratory Codes LOINC: 21667-0 ICD-10: Q74.3 Clinical summary This genetic test identifies pathogenic variants in the TNNI2 gene associated with Distal Arthrogryposis Type 2B.
TEST-4245 TNNI3 Gene (Familial Restrictive Cardiomyopathy Type 1) Genetic Test This test analyzes the TNNI3 gene for pathogenic variants associated with autosomal dominant familial restrictive cardiomyopathy type 1.	Whole Blood / FTA Card / Extracted DNA	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TNNI3 gene", "Large deletions or duplications in the TNNI3 gene"] Parameters [] Preparation [] Indications ["Diagnosis of familial restrictive cardiomyopathy type 1", "Cascade family screening for TNNI3 mutations", "Risk stratification in individuals with a family history"] Measurement technique Confirm with laboratory Codes LOINC: 78920-1 ICD-10: I42.5 Clinical summary This test analyzes the TNNI3 gene for pathogenic variants associated with autosomal dominant familial restrictive cardiomyopathy type 1.
TEST-4316 TNNI3 Gene Cardiomyopathy, Dilated Type 2A Genetic Test This test evaluates the TNNI3 gene for pathogenic variants associated with autosomal dominant dilated cardiomyopathy type 2A.	Peripheral Whole Blood (EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["TNNI3 gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"] Parameters [] Preparation ["No fasting required", "No medication adjustments required", "Continue all prescribed cardiac medications"] Indications ["Diagnosis of idiopathic dilated cardiomyopathy", "Family history of dilated cardiomyopathy or sudden cardiac death", "Unexplained left ventricular dysfunction"] Measurement technique Confirm with laboratory Codes LOINC: 94037-7 ICD-10: I42.0 Clinical summary This test evaluates the TNNI3 gene for pathogenic variants associated with autosomal dominant dilated cardiomyopathy type 2A.
TEST-4278 TNNI3 Gene Familial Hypertrophic Cardiomyopathy Type 7 DNA Test This test identifies pathogenic variants in the TNNI3 gene associated with familial hypertrophic cardiomyopathy type 7.	Peripheral whole blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TNNI3 gene", "Single nucleotide variants", "Small insertions/deletions", "Splice-site mutations"] Parameters [] Preparation ["Detailed clinical history required", "Mandatory pre-test genetic counselling session", "Construction of a three-generation pedigree"] Indications ["Diagnosis of familial hypertrophic cardiomyopathy type 7", "Family screening for FHC7", "Risk assessment in individuals with family history"] Measurement technique Confirm with laboratory Codes LOINC: 93929-2 ICD-10: I42.1 Clinical summary This test identifies pathogenic variants in the TNNI3 gene associated with familial hypertrophic cardiomyopathy type 7.
TEST-5298 TNNT1 Gene Nemaline Myopathy Type 5 Genetic Test This test identifies pathogenic variants in the TNNT1 gene associated with nemaline myopathy type 5.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot on FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TNNT1 gene", "Coding region and splice site variants"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any bleeding disorders"] Indications ["Suspected nemaline myopathy type 5", "Congenital muscle disorder diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: G71.2 Clinical summary This test identifies pathogenic variants in the TNNT1 gene associated with nemaline myopathy type 5.
TEST-4286 TNNT2 Gene Cardiomyopathy (Familial Hypertrophic Type 2) Genetic Test This test evaluates the TNNT2 gene for pathogenic variants associated with familial hypertrophic cardiomyopathy type 2.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TNNT2 gene"] Parameters [] Preparation [] Indications ["Confirmation of clinical diagnosis of hypertrophic cardiomyopathy", "Identification of at-risk family members", "Guiding personalised treatment"] Measurement technique Confirm with laboratory Codes LOINC: 83290-0 ICD-10: I42.1 Clinical summary This test evaluates the TNNT2 gene for pathogenic variants associated with familial hypertrophic cardiomyopathy type 2.

Category overview

Genetics: overview

Understanding your unique biological blueprint offers a profound sense of clarity and empowers proactive health planning for you and your family. At DNA Labs UAE, our specialized Genetics division employs state-of-the-art molecular technologies to provide deep insights into hereditary markers and cellular mutations. This comprehensive genetics testing in the UAE equips your healthcare provider with the precise data needed to tailor your medical guidance effectively. Recognized among top diagnostic labs in Dubai and the UAE, we prioritize your peace of mind through strict confidentiality protocols and exceptionally fast, accurate reporting. Take the next step in your health journey. View our genetics diagnostic services, book a private home collection, or consult our specialized team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Genetics tests in Dubai & UAE

Genetics test prices

Genetics: overview

Use the test details as a conversation starter

Related Genetics categories